Robert Lande
Direktor/Vorstandsmitglied bei KNIGHT THERAPEUTICS INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
Robert N.
Lande is currently an Independent Director at Knight Therapeutics, Inc., President & Director at The FXCM Group LLC, Director at Biotoscana Investments SA, and Chief Financial Officer at Forex Capital Markets LLC.
Previously, he served as an Independent Director at Paladin Labs, Inc. from 2011 to 2014, President-Bell Canada International do Brasil at Bell Canada International, Inc., Managing Partner at RiverEdge Capital Partners LLC, Chief Financial Officer at Telecom Americas Ltd., and Chief Financial Officer at Global Brokerage, Inc. from 2011 to 2018.
He obtained his undergraduate degree from McGill University in 1984 and his MBA from John Molson School of Business in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2024 | 243 178 ( 0,24% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von Robert Lande
| Unternehmen | Position | Beginn |
|---|---|---|
| KNIGHT THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
| BIOTOSCANA INVESTMENTS S.A. | Direktor/Vorstandsmitglied | 25.11.2019 |
The FXCM Group LLC
 The FXCM Group LLC Financial ConglomeratesFinance The FXCM Group provides online foreign exchange, or FX, trading and related services. It operates as a holding company. The firm operates through two segments: Retail Trading and Institutional Trading. The company was founded by David Sakhai, Kenneth A. Grossman, Dror Niv, Eduard Yusupov and William Ahdout in 1999 and is headquartered in New York, NY. | Präsident | 01.01.2010 |
Forex Capital Markets LLC
 Forex Capital Markets LLC Investment Banks/BrokersFinance Forex Capital Markets LLC provides foreign exchange trading services. The firm offers services for institutional and individual investors. The company was founded in July 1999 by Ken Grossman, David Sakhai, Drew Niv, Michael J. Romersa, William Ahdout, and Eduard Yusupov and is headquartered in New York, NY. | Finanzdirektor/CFO | 20.10.2011 |
Ehemalige bekannte Positionen von Robert Lande
| Unternehmen | Position | Ende |
|---|---|---|
| GLOBAL BROKERAGE, INC. | Finanzdirektor/CFO | 08.02.2018 |
| PALADIN LABS INC. | Direktor/Vorstandsmitglied | 01.01.2014 |
Telecom Americas Ltd.
 Telecom Americas Ltd. Wireless TelecommunicationsCommunications Part of America Movil SAB de CV, Telecom Americas Ltd. provides radiotelephone communication services. The company is based in Hamilton, Bermuda. | Finanzdirektor/CFO | - |
RiverEdge Capital Partners LLC
 RiverEdge Capital Partners LLC Investment ManagersFinance RiverEdge Capital Partners LLC is a hedge fund manager located in Irvington, New York. | Corporate Officer/Principal | - |
Bell Canada International, Inc.
 Bell Canada International, Inc. Wireless TelecommunicationsCommunications The Company's principal activity is to own, develop and operate advanced communication systems. Currently, it is operating under a Plan of Arrangement, pursuant to which, it intends to monetize its assets in an orderly fashion and resolve outstanding claims against it with the objective of distributing the net proceeds to its shareholders and dissolving the business. | Corporate Officer/Principal | - |
Ausbildung von Robert Lande
| McGill University | Undergraduate Degree |
| John Molson School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GLOBAL BROKERAGE, INC. | Finance |
| KNIGHT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
Bell Canada International, Inc.
Bell Canada International, Inc. Wireless TelecommunicationsCommunications The Company's principal activity is to own, develop and operate advanced communication systems. Currently, it is operating under a Plan of Arrangement, pursuant to which, it intends to monetize its assets in an orderly fashion and resolve outstanding claims against it with the objective of distributing the net proceeds to its shareholders and dissolving the business. | Communications |
RiverEdge Capital Partners LLC
RiverEdge Capital Partners LLC Investment ManagersFinance RiverEdge Capital Partners LLC is a hedge fund manager located in Irvington, New York. | Finance |
The FXCM Group LLC
The FXCM Group LLC Financial ConglomeratesFinance The FXCM Group provides online foreign exchange, or FX, trading and related services. It operates as a holding company. The firm operates through two segments: Retail Trading and Institutional Trading. The company was founded by David Sakhai, Kenneth A. Grossman, Dror Niv, Eduard Yusupov and William Ahdout in 1999 and is headquartered in New York, NY. | Finance |
Forex Capital Markets LLC
Forex Capital Markets LLC Investment Banks/BrokersFinance Forex Capital Markets LLC provides foreign exchange trading services. The firm offers services for institutional and individual investors. The company was founded in July 1999 by Ken Grossman, David Sakhai, Drew Niv, Michael J. Romersa, William Ahdout, and Eduard Yusupov and is headquartered in New York, NY. | Finance |
Telecom Americas Ltd.
Telecom Americas Ltd. Wireless TelecommunicationsCommunications Part of America Movil SAB de CV, Telecom Americas Ltd. provides radiotelephone communication services. The company is based in Hamilton, Bermuda. | Communications |
Biotoscana Investments SA
 Biotoscana Investments SA Pharmaceuticals: MajorHealth Technology Biotoscana Investments SA operates as a holding company, which engages in the development, manufacturing and commercialization of advanced medicine. Its operations include oncology, onco-hematology, severe infectious diseases, genetic and rare conditions as well as immunology and inflammation. The company was founded in August 16, 2011 and is headquartered in Montevideo, Uruguay. | Health Technology |
